Guides/Reports
Testimony before the House Energy & Commerce Subcommittee: “Opportunities to Improve the 340B Drug Pricing Program”
Statement of the American Hospital Association for the Energy and Commerce Subcommittee on Health of the U.S. House of Representatives for the July 11, 2018 hearing on “Opportunities to Improve the 340B Drug Pricing Program”
On behalf of our nearly 5,000 member hospitals, health systems and other health care organizations, including more than 1,900 hospitals that participate in the 340B drug savings program, and our clinician partners – including more than 270,000 affiliated physicians, 2 million nurses and other caregivers – the American Hospital Association (AHA) appreciates the opportunity to express our strong support for the 340B program.
Read the full statement below.
Key Resources
Related Resources
Letter/Comment
AHA Center for Health Innovation Market Scan
Guides/Reports